Minami Yusuke, Matsumoto Seiichi, Ae Keisuke, Sugiura Yoshiya
Division of Orthopedic Oncology, The Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan.
Clinical Genetic Oncology, The Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan.
Oxf Med Case Reports. 2019 Apr 16;2019(4):omz024. doi: 10.1093/omcr/omz024. eCollection 2019 Apr.
Synovial sarcoma is a malignant tumor, it accounts for approximately 5-10% of the soft tissue sarcoma, and mainly develops in the para-articular regions in adolescents and young adults. We reported a case of synovial sarcoma extending into the vastus intermedius muscle beyond the intermuscular septum which is considered to be the greatest barrier to ensuring a safety margin in musculoskeletal surgery. Preoperative sequential MRI showed the intermuscular-septum line and direct tumoral invasion beyond the intermuscular septum. A histopathological examination showed the direct invasion to the intermuscular septum. Synovial sarcoma seldom shows such direct invasive pattern to barriers, much less the robust barrier like an intermuscular septum. To our knowledge, no previous study has reported such unique extension of a synovial sarcoma beyond the intermuscular septum. Surgeons should be aware of the potential vulnerability of the intermuscular septum.
滑膜肉瘤是一种恶性肿瘤,约占软组织肉瘤的5%-10%,主要发生于青少年和年轻成年人的关节旁区域。我们报告了一例滑膜肉瘤延伸至肌间隔以外的股中间肌,肌间隔被认为是确保肌肉骨骼手术安全切缘的最大障碍。术前连续MRI显示了肌间隔线以及肿瘤直接侵犯至肌间隔以外。组织病理学检查显示肿瘤直接侵犯至肌间隔。滑膜肉瘤很少表现出这种直接侵犯屏障的模式,更不用说像肌间隔这样强大的屏障了。据我们所知,此前没有研究报道过滑膜肉瘤如此独特地延伸至肌间隔以外。外科医生应意识到肌间隔可能存在的易侵犯性。